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CASE REPORTA predominantly left-sided skin reaction to
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Unilateral skin reactions are rare in patients with
neurologic impairments caused by vascular or
metastatic disease. The pathophysiology of these
unilateral reactions has not been characterized,
although recent research in neurophysiology
provides a few clues.CASE REPORT
Mr A (a 49-year-old man with right hemiplegia for
the previous 18 months as a result of an ischemic
stroke) was treated with pristinamycin (1 g, 3 times a
day) for erysipelas of the right leg.
The patient had coronary heart disease and a
history of alcohol and tobacco consumption. There
had been no recent changes in his medications. He
was treated for 2 years with amlodipine, baclofen,
bisoprolol, cetirizine, fluoxetine, lysine acetylsalicy-
late, levetiracetam, pregabalin, rabeprazole, and
atorvastatin. Seven days after the initiation of
antibiotic treatment, he presented with left-sided
maculopapular exanthema (MPE) on the trunk and
the lower and upper limbs. The skin eruption was
less widespread on the right upper and lower limbs
(Figs 1 and 2). The patient did not have fever,
mucosal erosions, skin blisters, adenopathy, diges-
tive symptoms, or any severe systemic signs sugges-
tive of a viral infection. The Naranjo score was 4,
which means that an adverse drug reaction caused
by pristinamycin was possible. Laboratory tests
found hypereosinophilia (0.6 g/L) but no other
abnormalities. Histologic analysis of the skin biopsy
found an eczemalike pattern with a few necrotic
keratinocytes and eosinophilic, perivascular, andthe Service de Dermatologie et Venereologie,a and Service
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inantly left-sided, MPE-type adverse reaction of the
skin due to pristinamycin. The eruption resolved
within 10 days (with no need for treatment other
than pristinamycin withdrawal) and did not recur.
DISCUSSION
Cutaneous side effects of pristinamycin (an anti-
biotic related to the macrolides) are rare. The most
frequently reported adverse events of this kind are
delayed-type, MPE-like reactions. There are also
some reports of type 1 hypersensitivity (urticaria
and angioedema), Steven Johnson syndrome, Lyell
syndrome, acute generalized pustulosis, drug
reactions with eosinophilia and systemic symptoms,
and even a pityriasis roseaelike eruption. In view of
the absence of other likely etiologies (and especially
viral causes), the chronology of the eruption, and the
fact that MPE-like reactions are the most frequent
delayed-type hypersensitivity (DTH) skin reaction to
antibiotics in general and to pristinamycin in partic-
ular, we considered that the MPE was an adverse
reaction to the antibiotic. We would have preferred
to perform skin tests to confirm this hypothesis, but,
unfortunately, the patient was lost to follow-up soon
after this episode. Bilateral skin tests might have
reproduced the predominantly left-sided reactivity,
although this type of exposure to the allergen mightJAAD Case Reports 2016;2:84-6.
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Fig 1. Maculopapular exanthema, left-sided.
Fig 2. Maculopapular exanthema, left-sided.
Fig 3. Eczemalike pattern with a few necrotic keratino-
cytes and eosinophilic, perivascular, dermal infiltration.
(Hematoxylin-eosin-safran stain.)
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(sometimes referred to angry back or excited skin
syndrome) or an even more serious systemic
reaction.
We found 5 other literature reports of unilateral
adverse skin reactions: 2 cases involved the targeted
therapies, sorafenib and cetuximab, and the 3 others
involved the antimitotics, capecitabine and doce-
taxel (Table I). Several pathophysiologic hypotheses
may be considered. It is thought that hand-foot
syndrome (HFS) may result from mechanical stress.
Hence, hemiplegia might protect the affected side
from this type of syndrome.1 Given that many stroke
patients have atherosclerosis, poor vascular flow
Table I. Unilateral adverse reactions: 5 case reports from the literature
Study Unilateral adverse reaction/body side Neurologic disorder Drug
Almeida da Cruz et al1 Right HFS Left hemiplegia Capecitabine
Disel et al2 Left HFS Right hemiplegia Capecitabine
Truchuelo et al3 Onycholysis of the right hand Left hemiplegia Docetaxel
Chanal et al4 Right HFS Hemiplegia of the left arm Sorafenib
Kerob et al5 Right facial folliculitis Right facial palsy Cetuximab
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metabolites (and thus a lower risk of HFS develop-
ment) on the paretic side.2 Abnormal innervation
and lower levels of microtrauma on the paralyzed
side might slow nail growth and thus reduce the risk
of onycholysis. Lastly, lymphatic stasis might account
for folliculitis on the paralyzed side because of the
persistence of cetuximab binding to the epidermal
growth factor receptor.5 The latter hypothesis was
already been suggested in a report on unilateral
pemphigoid in a hemiplegic patient.6 However,
none of the aforementioned side effects were
immune reactions like MPE. To the best of our
knowledge, a predominantly unilateral, MPE-like
skin reaction (ie, one with an immunoallergic
mechanism) has not been described previously.
The etiology of unilateral MPE has not been
characterized, although several hypotheses can be
considered. As mentioned above, lower levels of
microtrauma and lymphatic stasis on the paralyzed
side might protect the body by slowing down the
flow of inflammatory mediators.
However, we propose a new hypothesis: immune
impairment on the paralyzed side (probably related
to T lymphocytes) may reduce the incidence or
severity of exanthema. The relationships between
the immune system and the central nervous system
have been studied since the 1980s. Levine et al7 and
then Tarkowski et al8 reported that T cell immunity
was asymmetric in hemiplegic patients. On the basis
of the reactions to intradermal injections of
tuberculin, these researchers found that patients
with brain lesions caused by stroke displayed
lateralized, DTH reactions.
The lateralization of DTH responses changed over
time and was related to the severity, site, and the
stroke phase (acute vs chronic).9 Patients in the early
phase of a minor stroke displayed a less-intense DTH
response on the paretic side than on the nonparetic
side, whereas patients with major stroke displayed alarger DTH response on the paretic side than on the
nonparetic side.9 The lateralization may be reversed
in the chronic phase, regardless of the stroke’s
severity.10
We observed a rare case of a unilateral adverse
skin reaction on the valid body side of a patient with
stroke-induced hemiplegia. This case illustrates that
poststroke immune impairments may occur on the
paralyzed side.
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